BioMarin Pharmaceutical
BMRN
#1351
Rank
A$20.40 B
Marketcap
$106.97
Share price
-1.23%
Change (1 day)
-19.02%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): A$0.82 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$2.85 Billion. , an increase over its 2023 earnings that were of A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 A$0.85 B187.31%
2023 A$0.29 B26.07%
2022 A$0.23 B-298.51%
2021 -A$0.12 Billion78.04%
2020 -A$67.1 Million-55.36%
2019 -A$0.16 Billion-33.56%
2018 -A$0.23 Billion297.78%
2017 -A$56.88 Million-95.68%
2016 -A$1.32 Billion437.12%
2015 -A$0.25 Billion23.91%
2014 -A$0.2 Billion-29.25%
2013 -A$0.28 Billion49.23%
2012 -A$0.19 Billion171.11%
2011 -A$69.17 Million103.01%
2010 -A$34.07 Million-3903.54%
2009 A$0.89 M-98.31%
2008 A$52.98 M-189.7%
2007 -A$59.08 Million51.02%
2006 -A$39.12 Million-61.58%
2005 -A$0.11 Billion-56.59%
2004 -A$0.24 Billion95.13%
2003 -A$0.13 Billion12.09%
2002 -A$0.11 Billion73.19%
2001 -A$61.91 Million18.32%
2000 -A$52.32 Million19.65%
1999 -A$43.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.8 Billion-193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.16 Billion-118.17%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.89 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.59 B 1,365.96%๐Ÿ‡ซ๐Ÿ‡ท France
-A$45.59 Million-105.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.34 B-60.08%๐Ÿ‡บ๐Ÿ‡ธ USA